ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
C6000041269 |
|
24939-03-5 |
Polyinosinic acid-polycytidylic acid (P I : C) - 90% |
0 | C19H27N7O16P2 | |
C6000041261 |
|
152-62-5 |
Dydrogesterone - 98% |
0 | C21H28O2 | |
C6000041260 |
|
41689-31-0 |
N-(2-Acetamido)iminodiacetic acid disodium salt - 98% |
0 | C6H11N2NaO5 | |
C6000041259 |
|
2105-43-3 |
FursultiamineHydrochloride - 98% |
0 | C17H27ClN4O3S2 | |
C6000041257 |
|
14917-55-6 |
METHYL ALPHA-L-RHAMNOPYRANOSIDE - 98% |
0 | C7H14O5 | |
C6000041256 |
|
9036-66-2 |
ARABINOGALACTAN - 98% |
0 | C20H36O14 | |
C6000041255 |
|
644-76-8 |
1,6-ANHYDRO-BETA-D-GALACTOPYRANOSE - 98% |
0 | C6H10O5 | |
C6000041254 |
|
67314-36-7 |
Hexa-O-acetyl-cellobial - 98% |
0 | C24H32O15 | |
C6000041253 |
|
53657-42-4 |
2-methyl-3,4-dihydro-2H-pyran-3,4-diol - 98% |
0 | C6H10O3 | |
C6000041252 |
|
7355-18-2 |
METHYL 1,2,3,4-TETRA-O-ACETYL-BETA-D-GLUCURONATE - 98% |
0 | C15H20O11 | |
C6000041251 |
|
53008-63-2 |
Methyl 2,3,4,6-Tetra-O-benzyl-a-D-galactopyranoside - 98% |
0 | C35H38O6 | |
C6000041250 |
|
20031-21-4 |
1,2-O-Isopropylidene-alpha-D-xylofuranose - 98% |
0 | C8H14O5 | |
C6000041249 |
|
526-99-8 |
MUCIC ACID - 98% |
0 | C6H10O8 | |
C6000041248 |
|
10039-26-6 |
LACTOSE - 98% |
0 | C12H24O12 | |
C6000041247 |
|
3615-37-0 |
D-( )-FUCOSE - 98% |
0 | C6H12O5 | |
C6000041246 |
|
69313-67-3 |
Potassium lactobionate - 98% |
0 | C12H22KO12* | |
C6000041245 |
|
87-73-0 |
D-Glucaric acid - 98% |
0 | C6H10O8 | |
C6000041244 |
|
637334-45-3 |
Ocrelizumab - 98% |
0 | — | |
C6000041243 |
|
1610943-06-0 |
Emicizumab - 98% |
0 | — | |
C6000041242 |
|
1190264-60-8 |
dupilumab - 70%~130% |
0 | — | |